A Mad2-Mediated Translational Regulatory Mechanism Promoting S-Phase Cyclin Synthesis Controls Origin Firing and Survival to Replication Stress by S. Gay et al.
ArticleAMad2-Mediated Translational RegulatoryMechanism
Promoting S-Phase Cyclin Synthesis Controls Origin
Firing and Survival to Replication StressGraphical AbstractHighlightsd Mad2 promotes origin firing in rad53 defective cells upon
replication stress
d Rad53 inhibits Clb5 degradation, while Mad2 promotes Clb5
synthesis
d Mad2 inhibits Caf204E-BP by modulating its interaction with
the translation machinery
d The role of Mad2 in translation does not depend on other SAC
proteinsGay et al., 2018, Molecular Cell 70, 628–638
May 17, 2018 ª 2018 The Author(s). Published by Elsevier Inc.
https://doi.org/10.1016/j.molcel.2018.04.020Authors
Sophie Gay, Daniele Piccini,
Christopher Bruhn, ...,
Walter Carotenuto, Stefano Biffo,
Marco Foiani
Correspondence
sophie.gay@ifom.eu (S.G.),
marco.foiani@ifom.eu (M.F.)
In Brief
Here, Gay et al. show that, in addition to
its well-established role in the spindle
checkpoint, Mad2 promotes translation
of S-phase cyclin mRNAs. This S-phase
role of Mad2 is critical for cell survival
following replication stress.
Molecular Cell
ArticleAMad2-MediatedTranslationalRegulatoryMechanism
Promoting S-Phase Cyclin Synthesis Controls
Origin Firing and Survival to Replication Stress
Sophie Gay,1,* Daniele Piccini,1 Christopher Bruhn,1 Sara Ricciardi,2,3 Paolo Soffientini,1 Walter Carotenuto,1
Stefano Biffo,2,3 and Marco Foiani1,3,4,*
1IFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy
2Fondazione Istituto Nazionale Genetica Molecolare, Via Francesco Sforza, 32, 20122 Milan, Italy
3Universita` degli Studi di Milano, Via Celoria 26, 20133 Milan, Italy
4Lead Contact
*Correspondence: sophie.gay@ifom.eu (S.G.), marco.foiani@ifom.eu (M.F.)
https://doi.org/10.1016/j.molcel.2018.04.020SUMMARY
Cell survival to replication stress depends on
the activation of the Mec1ATR-Rad53 checkpoint
response that protects the integrity of stalled forks
and controls the origin firing program. Here we found
that Mad2, amember of the spindle assembly check-
point (SAC), contributes to efficient origin firing and
to cell survival in response to replication stress. We
show that Rad53 and Mad2 promote S-phase cyclin
expression through different mechanisms: while
Rad53 influences Clb5,6 degradation, Mad2 pro-
motes their protein synthesis. We found that Mad2
co-sediments with polysomes andmodulates the as-
sociation of the translation inhibitor Caf204E-BP with
the translation machinery and the initiation factor
eIF4E. This Mad2-dependent translational regulatory
process does not depend on other SAC proteins.
Altogether our observations indicate that Mad2 has
an additional function outside of mitosis to control
DNA synthesis and collaborates with the Mec1-
Rad53 regulatory axis to allow cell survival in
response to replication stress.
INTRODUCTION
Inhibition of replication fork progression activates the Mec1ATR-
mediated checkpoint that phosphorylates downstream effectors
such as Rad53Chk1 (Branzei and Foiani, 2009). Once activated,
the replication checkpoint stabilizes stalled replication forks
(Sogo et al., 2002), stimulates dNTP production (Zhao et al.,
1998; Zhao and Rothstein, 2002), influences origin firing (Marhei-
neke and Hyrien, 2004; Santocanale and Diffley, 1998), regulates
histone protein levels (Gunjan and Verreault, 2003), and releases
topological tensions (Bermejo et al., 2012). Later in the cell cycle,
the spindle assembly checkpoint (SAC) controls the bipolar
attachment of chromosomes tomicrotubules (Foley and Kapoor,
2013; Musacchio, 2015). Abnormal physical tension between
chromosomes and microtubules is sensed at the kinetochore628 Molecular Cell 70, 628–638, May 17, 2018 ª 2018 The Author(s).
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network) (Godek et al., 2015) that recruits the mediator complex
Mad1/Mad2 (Figure 1A). After activation, Mad2 forms a soluble
effector complex with the proteins Bub3, Mad3BubR1, and
Cdc20, which inhibits the anaphase-promoting complex (APC)
(Fraschini et al., 2001; Sudakin et al., 2001). APC inhibition
prevents the degradation of mitotic cyclins (Clb2CyclinB) and
Pds1Securin, thus blocking the metaphase/anaphase transition
(Shirayama et al., 1999; W€asch and Cross, 2002). Deregulation
of SAC protein expression causes chromosome instability and
cancer (Schuyler et al., 2012; Suijkerbuijk and Kops, 2008).
Despite the persistence of Mad1 and Mad2 proteins
throughout the cell cycle, their role outside of mitosis is elusive.
During interphase, Mad1 and Mad2 mainly localize to nuclear
pores (Campbell et al., 2001; De Souza et al., 2009; Lee et al.,
2008; Lussi et al., 2010). In the yeast Saccharomyces cerevisiae,
Mad1, but not Mad2, favors protein nuclear transport and mod-
ulates nuclear import following SAC activation (Cairo et al.,
2013). Mad2 has been shown to physically interact with proteins
involved in transcription, mRNA processing, and translation
(Batisse et al., 2009; Graumann et al., 2004; Uetz et al., 2000;
Wong et al., 2007; Yu et al., 2008), although the involvement of
Mad2 in these processes is still elusive.
We found that Mad2 contributes to cell survival in response to
replication stress when the Rad53 checkpoint is defective. While
Rad53 influences Clb5,6 degradation, Mad2 promotes Clb5,6
protein synthesis through its association with the inhibitor of
translation Caf204E-BP. Altogether our observations indicate
that Mad2, and not the other SAC proteins, counteracts the as-
sociation of Caf20 with the translational machinery and stabilizes
the complex formation between Caf20 and the initiation factor
Cdc33eIF4E. Hence, Mad2 acts also during S-phase to promote
origin firing and, together with the Rad53-mediated checkpoint,
contributes to cell survival in response to replication stress.RESULTS
Mad2 Contributes to Cell Survival in Response to
Replication Stress when Rad53 Is Not Functional
We investigated whether spindle checkpoint proteins were
required for survival to hydroxyurea (HU)-induced replicationPublished by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. MAD2 Deletion Increases the Sensitivity of rad53 Mutants to Replication Stress
(A) Schematic representation of the SAC activation.
(A–C) Cells were spotted in 5-fold (A and C) or 2-fold (B) serial dilutions on YPDA/YP-Gal/HU/MMS or camptothecin plates, or on plates irradiated with UV.
Relative growth was assayed after 2 days of culture at 28C. The rad53-K227A allele is marked as rad53, and the GAL1-rad53-D339A allele is marked as
GAL1-rad53.
(D) DNA damage induced by replication stress was monitored by western blot analysis using anti-phosphorylated H2AX antibodies. Cells were synchronized in
G1 and released into YPD + 200 mM HU. Pgk1 was used as a loading control.stress (Krakoff et al., 1968). The HU sensitivity of mad1D and
mad2D mutants was comparable to the one of isogenic wild-
type (WT) cells (Figure 1A). However, when combined with the
rad53-K227A mutation, which retains 10% of Rad53 kinase ac-
tivity (Zheng et al., 1993), mad2D synergistically enhanced the
HU sensitivity of rad53-K227A, while Mad2 overexpression
ameliorated the rad53 HU sensitivity (Figure 1B). mad1D,
mad3D, and bub3D did not display any synthetic interactions
with the rad53 mutation, and the triple mutant rad53-K227A
mad1D mad2D exhibited the same HU sensitivity of the rad53-
K227A mad2D double mutant (Figure 1B). Once activated,
Mad2 inhibits the APC, which degrades the securin Pds1, thus
avoiding premature chromatid separation (Shirayama et al.,
1999) (Figure 1A). We compared the HU sensitivity of rad53-
K227A pds1D and rad53-K227A mutants (Figure 1B) and found
that Pds1 did not contribute to the response to replication
stress in a rad53 background, thus suggesting that the
enhanced HU sensitivity of rad53-K227A mad2D mutants wasnot caused by premature chromatid segregation. Overexpres-
sion of the dominant-negative rad53-K339A allele also caused
synthetic HU sensitivity when combined withmad2D (Figure 1B).
We conclude that specifically Mad2, within the SAC apparatus,
is required for cell survival to replication stress in a rad53
background.
Mad2 is the only component of the spindle checkpoint con-
taining a HORMA domain (for Hop1, Rev7, and MAd2) (Aravind
and Koonin, 1998); we tested whether the enhanced HU sensi-
tivity caused by mad2D was a common feature associated
with the loss of a protein carrying such a domain. Rev7, a subunit
of DNA polymerase zeta, is involved in translesion synthesis, and
the HORMA domains of Rev7 and Mad2 can partially substitute
for each other in vitro (Hanafusa et al., 2010). However, rev7D did
not exhibit any synthetic defect with rad53 in the presence of HU
(Figure S1A). Moreover, mad2D did not modify the levels of
Rad53 phosphorylation in response to replication stress
(Figure S1B).Molecular Cell 70, 628–638, May 17, 2018 629
Rad53 mediates cell survival under replication stress condi-
tions but also under DNA damaging conditions. We tested
the effect of MAD2 deletion in cells treated with the alkylating
agent methyl methan-sulfonate (MMS); ultraviolet (UV) radia-
tion, which leads to the formation of thymine dimers; or camp-
tothecin (CPT), which forms a covalent complex between
topoisomerase I and DNA. In all cases rad53-K227A mutants
exhibited hypersensitivity compared to WT cells (Figure 1C);
however, the combination of MAD2 deletion with rad53-
K227A mutation did not cause synthetic growth defects upon
DNA damage (Figure 1C). These results suggest that MAD2
deletion specifically affects the HU-induced replication stress
response and not the DNA damage response of rad53-K227A
mutants. Accordingly, the levels of H2AX phosphorylation, a
readout of DNA damage, were comparable in WT and mad2D
cells as well as in rad53-K227A and rad53-K227A mad2D mu-
tants (Figure 1D).
Mad2 Influences Origin Firing in Response to
Replication Stress
We then investigated whether the absence of Mad2 affected
replication dynamics. WT, mad1D, mad2D, and mad1D mad2D
cells were released from G1 into 200 mM HU for 1, 2, or 3 hr
and analyzed by neutral-neutral 2D gels electrophoresis after
in vivo chromatin psoralen crosslinking (Brewer and Fangman,
1987). At 1 hr in HU, all strains accumulated, at the ARS305 lo-
cus, bubble intermediates, a readout of origin firing, and large
Y structures, indicative of an asymmetric progression of the
sister forks (Figure S2A). The replication intermediates progres-
sively diminished at 2 and 3 hr in HU as a result of fork progres-
sion outside the restriction fragment analyzed. The quality and
the kinetics of appearance/disappearance of the replication
intermediates were comparable in all the strains analyzed.
Moreover, the levels of incorporation of bromodeoxyuridine
(BrdU), a thymidine analog, analyzed at early origins (ARS305,
ARS306, ARS607), and at the centromeric origin ARS308,
were also comparable in WT and mad2D strains released from
G1 into HU (Figures S2B and S2C). As expected, no BrdU incor-
poration was detected at inactive origins (Figure S2D). We
conclude that the deletion of MAD2 per se does not influence
origin firing.
We then examined by 2D gels the ARS305 replication interme-
diates of rad53-K227A, rad53-K227A mad1D, rad53-K227A
mad2D, and rad53-K227A mad1D mad2D strains released
fromG1 into HU (Figure 2A). rad53-K227Amutants accumulated
the typical intermediates resulting from origin firing and progres-
sive fork collapse (Lopes et al., 2001). rad53-K227A and rad53-
K227A mad1D mutants exhibited comparable replication
profiles. However, the deletion of MAD2 in a rad53-K227A or
rad53-K227A mad1D backgrounds caused a significant reduc-
tion (about five times) in the levels of replication intermediates,
without altering their kinetics of appearance/disappearance.
BrdU immunoprecipitation and quantitative PCR confirmed
that the deletion of MAD2 in rad53-K227A mutants reduces
origin firing at early origins and extended this observation to
late origins (ARS106) (Figures 2B and 2C). We conclude that in
the absence of a functional Rad53, MAD2 deletion leads to a
decrease in origin firing efficiency.630 Molecular Cell 70, 628–638, May 17, 2018Mad2 and the Intra-S Checkpoint promote the
Expression of the S-Phase Cyclins Clb5,6
Replication origin firing is a two-step process mediated by origin
licensing and origin activation (Bell and Dutta, 2002; Diffley and
Labib, 2002). During this later step, a subset of the potential or-
igins bound by a pre-replicative complex are converted into
active origins through a phosphorylation cascade which involves
the DBF4-dependent kinase DBF4/Cdc7 and the cyclin-depen-
dent kinases (CDKs) Clb5/Cdc28 and Clb6/Cdc28. clb5D cells
exhibit a prolonged S-phase, a decrease in late origin firing in
the absence of replication stress, and an increased sensitivity
to HU (Donaldson et al., 1998; Epstein and Cross, 1992; Hsu
et al., 2011). Moreover, CLB5 deletion is lethal in combination
with a defective intra-S checkpoint, suggesting that Clb5 levels
become particularly critical in the absence of a functional intra-
S checkpoint (Gibson et al., 2004; Manfrini et al., 2012). We
investigated whether Clb5 levels were affected by MAD2 dele-
tion or RAD53 mutations. WT, mad2D, rad53-K227A, and
rad53-K227A mad2D cells were synchronized in G1 and
released into S-phase. Clb5 levels were analyzed throughout
the cell cycle by western blotting. As previously described (Jack-
son et al., 2006), Clb5 accumulation started roughly 30 min after
release from G1. Its levels peaked after 60 min from release and
declined when cells went through mitosis (Figures 3A and 3B).
Clb5 expression profile was similar in mad2D and WT cells,
even though we observed a 40% loss in Clb5 levels at 75 min
from the G1 release in mad2D cells compared to WT. We note
that this loss was not due to a faster S-phase since FACS profiles
were comparable in WT and mad2D cells (Figure 3B). In rad53
mutants, Clb5 accumulated with similar kinetics to WT cells.
The contribution of Mad2 in the maintenance of Clb5 levels
was far more evident when comparing rad53-K227A and
rad53-K227A mad2D cells. Although the kinetics of Clb5 accu-
mulation were similar between the two strains, Clb5 protein
levels were between 30% and 60% less abundant in rad53-
K227A mad2D cells compared to rad53-K227A cells (45–
90 min after release from G1). Altogether, these results suggest
that Mad2 influences the accumulation of Clb5 levels, even in the
absence of replication stress.
We then studied the effect of replication stress on the Clb5
accumulation by releasing cells in complete medium in the pres-
ence of HU (Figure 3A). As previously described (Palou et al.,
2010), in WT cells, Clb5 levels peaked 60 min after G1 release
both in the presence and in the absence of replication stress.
However, Clb5 levels were stabilized for a longer time in the pres-
ence of HU (Clb5 expression decline after 90 min of G1-release
without HU versus 150 min in the presence of replication stress)
(Figure 3A). Both MAD2 deletion and rad53 mutations acceler-
ated Clb5 decline. Indeed, a 60% reduction in Clb5 levels was
observed 30 min before in mad2D and in rad53-K227A cells
compared to WT. Clb5 reduction was even more pronounced
in rad53-K227A mad2D cells in which Clb5 became hardly
detectable. We conclude that both Mad2 and Rad53 contribute
to maintain Clb5 levels in the presence of replication stress.
Furthermore, their additive effect on Clb5 suggests that Rad53
and Mad2 maintain Clb5 levels though different mechanisms.
Similar results were obtained for the other S-phase cyclin, Clb6
(Figure S3A). We note that Mad2 did not affect the general
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Figure 2. Mad2 Stimulates Origin Firing in rad53-K227A Cells
(A) 2D gel analysis of replication intermediates in rad53-K227A, rad53-K227Amad1D, rad53-K227Amad2D, rad53-K227Amad1Dmad2D cells at the early origin
ARS305. Cells were released from G1 into S-phase at 25C in 200 mM HU. Quantification of replication intermediates was plotted on the histogram. Intensity of
the bubble arc was divided by the intensity of the relative monomer spot, normalized against rad53-K227A cells.
(B and C) BrdU immunoprecipitation and quantitative PCR on early (B) and late (C) origins in rad53-K227A and rad53-K227A mad2D cells. Cells were released
from G1 into S-phase at 25C in the presence of 200mMHU and 200 mg/ml BrdU. BrdU fold increase was calculated as a ratio:IP/input, normalized against BrdU
signal of rad53-K227A cells after 45 min of release. Scale bars represent the SD of three independent experiments. Asterisks indicate statistically significant
differences between cell lines (one-tailed Wilcoxon test with a p value%0.05).protein expression, since the abundance of the replication factor
Orc2, of the cyclin Clb2, or of the housekeeping gene Pgk1, was
not reduced by MAD2 deletion (Figure S3B).
Rad53 Inhibits Clb5 Degradation under Replication
Stress
The decrease in cyclin expression that we have previously
observed can result from a defect in transcription, translation,
and/or protein degradation. To test the contribution of Rad53
or Mad2 in transcription, WT, mad2D, rad53-K227A, and
rad53-K227A mad2D cells were synchronized in G1 and
released into S-phase in the presence of 200 mM HU. mRNA
abundance was measured by reverse transcription (RT) and
qPCR. As shown in Figure 3C, Clb5 transcription initiates at
the end of the G1 phase, 30 min after a factor release. The levels
of Clb5 transcripts were similar in all strains. We conclude that
neither MAD2 deletion nor rad53 mutation influences Clb5 tran-
scription. Similar results were observed for the other S-phase cy-
clin, Clb6 (Figures S3C and S3D).
We then investigated whether Mad2 or Rad53 could have an
impact on Clb5 degradation. WT, rad53-K227A, and rad53-K227A mad2D cells were synchronized in G1 and released
into S-phase in the presence of 200 mM HU and 100 mM
MG132, a proteasome inhibitor, which specifically protects
short-lived protein from degradation (Lee and Goldberg,
1996). Under MG132 and HU treatment, Clb5 protein levels
remained almost constant in WT cells, even after 3 hr of
release (Figure 3D). A similar result was observed in rad53-
K227A cells. While the levels of Clb5 were reduced by 70%
after 150 min of release without MG132, Clb5 levels decreased
only by 15% during the same period in the presence of MG132
(Figures 3D and S3E). We ruled out a cell-cycle issue, since
FACS profiles were comparable with or without MG132 (data
not shown).
The same strategy was used to study the contribution of
Mad2 to Clb5 degradation. Contrary to what we observed in
rad53-K227A cells, the level of Clb5 gradually decreased under
HU treatment in rad53-K227A mad2D cells, even in the
presence of MG132 (Figure 3D). We conclude that Rad53
protects Clb5 from degradation during HU treatment, while
Mad2 acts through a mechanism that is not affected by
MG132 treatment.Molecular Cell 70, 628–638, May 17, 2018 631
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Figure 3. Rad53 and Mad2 Regulate Clb5 Expression
(A) Expression of Clb5-HA was followed throughout the cell-cycle progression in WT, mad2D, rad53-K227A, and rad53-K227A mad2D cells by western blot
analysis. Pgk1 and Ponceau S were used as loading controls. Cells were released from G1 into S-phase at 25C in YPD ± 200 mM HU. In the absence of HU,
a factor was re-added in the medium after 40 min of release in order to avoid cell re-entry into a new cell cycle. Clb5/Pgk1 signal ratio was plotted for each
condition, using WT/rad53-K227A cells at 60 min as a reference. The error bars represent the SD of two independent experiments.
(B) WT,mad2D, rad53-K227A, and rad53-K227A mad2D cells were released from G1 into S-phase at 25C in YPD ± 200 mM HU. The cellular DNA content was
determined by FACS analysis at the indicated time points.
(C) Total RNAswere extracted from cells synchronized in G1 or released fromG1 into S-phase at 25C in YPD + 200mMHU. After reverse transcription, the levels
of Clb5 mRNA were determined by quantitative PCR. The ratio between the transcription level of CLB5 and the average expression of two reporter genes (TAF10
and ALG9) was plotted on a histogram. The error bars represent the SD of two independent experiments.
(legend continued on next page)
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Mad2 Stimulates Clb5 Synthesis through 4E-BP
Inhibition
High-throughput screenings performed in yeast, human, and
plants have previously uncovered some intriguing physical inter-
actions between Mad2 and translation factors (Table S1). These
observations, added to our results, suggest that Mad2 could be
implicated in Clb5 mRNA translation. To test this possibility, we
quantified the translation rate of Clb5mRNA in rad53-K227A and
rad53-K227A mad2D cells (Figures 4A and S4). Cells were syn-
chronized in G1 and released into S-phase for 45min in the pres-
ence of HU. Cycloheximide was added to freeze the ribosomes
onto the translatingmRNAs. Cytoplasmic, monosome, and poly-
some fractions were separated on a sucrose gradient, and
mRNA levels in polysomes (high translation) and monosomes
(low translation) were measured by RT-qPCR. We observed
that the deletion of MAD2 shifted Clb5 mRNA from heavy poly-
somes to smaller polysomes and monosomes, confirming that
Mad2may impact the translation process of Clb5mRNA (Figures
4A and S4). We then investigated whether Mad2 co-sediments
with polysomes by performing a western blot analysis on su-
crose gradient fractions (Figure 4B). We observed that Mad2
co-fractionated with heavy polysomes in an EDTA- and RNase
I-dependent manner (addition of EDTA leads to the separation
of the 40S and 60S ribosomal subunits while RNase I is an endor-
ibonuclease that preferentially degrades single strand RNA). This
result supports the hypothesis that Mad2 interacts with the
translational machinery. Interestingly, in S. cerevisiae, two inde-
pendent screenings identified the translation factor Caf20 as a
physical partner of Mad2 (Castelli et al., 2015; Graumann et al.,
2004). Caf20 has been identified as a repressor of the cap-
dependent translation and as a homolog of the eIF4E binding
proteins (4E-BP). Consequently, we investigated whether
Mad2 could control Clb5 expression through aCaf20-dependent
mechanism. rad53-K227A, rad53-K227A caf20D, rad53-K227A
mad2D, and rad53-K227A mad2D caf20D cells were released
from G1 into 200 mM HU. Clb5 expression was analyzed by
western blot analysis (Figure 4C). The level of Clb5 protein re-
mained similar in rad53-K227A and rad53-K227A caf20D cells,
whereas Clb5 level increased in rad53-K227A mad2D caf20D
in comparison of rad53-K227A mad2D cells. In addition, we
found that the deletion of CAF20 suppressed the effect of
MAD2 deletion on Clb5 mRNA translation (Figure 4A). Alto-
gether, these results show that Mad2 impacts Clb5 mRNA trans-
lation in a Caf20-dependent manner.
Since CAF20 deletion restores the Clb5 expression in rad53-
K227A mad2D cells, we investigated the effect of CAF20 dele-
tion on replication origin firing and HU resistance. As expected,
we observed a global increase in origin firing in rad53-K227A
mad2D caf20D cells compared to rad53-K227A mad2D cells
(Figure 4D). In agreement with this result, CAF20 deletion sup-
pressed the HU sensitivity observed in rad53-K227A mad2D
cells (Figure 4E). Hence, Mad2 inhibits the 4E-BP Caf20, which
in turn counteracts Clb5 synthesis and efficient origin firing.(D) Expression of Clb5-HA upon treatment with a proteasome inhibitor (MG132) w
and rad53-K227Amad2D cells by western blot analysis. Pgk1 and Ponceau Swer
YPD + 200 mMHU + 100 mMMG132. Clb5/Pgk1 signal ratio was plotted for each
SD of two independent experiments.Mad2 Modifies the Interaction of Caf20 with the
Translational Machinery
Mad2 could inhibit Caf20 by at least two different mechanisms:
preventing its loading onto mRNA or counteracting its activity.
To test the first possibility, rad53-K227A and rad53-K227A
mad2D cells were released from G1 into S-phase for 45 min in
the presence of HU. Protein complexes were fixed onto mRNA
with formaldehyde. mRNAs bound to Caf20-HA were co-immu-
noprecipitated with an anti-HA antibody, reverse transcribed,
and quantified using quantitative PCR. As it was previously
described (Castelli et al., 2015; Costello et al., 2015), we found
that Caf20 was strongly bound to its own mRNA (Figure S5). In
addition, we observed that Clb5 mRNA was also bound by
Caf20. We confirmed that this association was specific, since
the attachment of Caf20 onto Clb5 mRNA was higher compared
to the binding of Caf20 onto a negative control (Alg9 mRNA).
However, we found that the deletion of MAD2 did not signifi-
cantly modify the recruitment of Caf20 onto Clb5 mRNA. This
result implies that Mad2 inhibits Caf20 by amechanism that is in-
dependent of the recruitment of Caf20 onto mRNAs.
We then investigated whether Mad2 could counteract the ac-
tivity of Caf20 by altering its interaction with the translational ma-
chinery. rad53-K227A and rad53-K227A mad2D cells were
synchronized in G1 and released into S phase for 45 min in the
presence of HU. We did not observe significant differences in
Caf20 protein levels by western blotting in the two strains (data
not shown). Caf20-HA and its interactors were co-immunopre-
cipitated. Protein partners were identified and quantified by
mass spectrometry. As it was previously described (Costello
et al., 2015), we found that Caf20 interacts with a large number
of translation factors implicated in both initiation and elongation
(Figures 5A and 5B; Table S2). In addition, we observed that, in
the absence of Mad2, Caf20 globally increases its association
with the whole translational machinery (translational initiation
factors and ribosomal proteins). Conversely, only the transla-
tional initiation factor eIF4E (Cdc33) reduced its affinity for
Caf20 in the absence of Mad2 (Figure 5B). We conclude that
Mad2 hinders the stable association between Caf20 and the
translation machinery, while it specifically stabilizes the binding
of Caf20 with eIF4E.
DISCUSSION
Many oncogenes and tumor suppressors target cyclins and
CDKs. For example, cMyc promotes Cyclin D/E/A transcription
(Bretones et al., 2015), while p53 favors the transcription of
p21, a CDK inhibitor (Georgakilas et al., 2017). In this study, we
uncovered a Mad2-mediated regulatory circuit promoting
S-phase cyclin expression. In particular, the levels of Clb5 and
Clb6 are compromised when Mad2 is ablated in unperturbed
conditions and in response to replication stress. Mad2 is a
well-known effector of the spindle checkpoint, but its S-phase
function is independent of the other SAC components likeas followed throughout the cell-cycle progression inWT,mad2D, rad53-K227A,
e used as loading controls. Cells were released fromG1 into S-phase at 25C in
condition, usingWT cells at 60 min as a reference. The error bars represent the
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Figure 4. Mad2 Controls Clb5 mRNA Translation via a Caf20-Dependent Mechanism
(A) Translational rate of Clb5 mRNA in rad53-K227A, rad53-K227A mad2D, and rad53-K227A mad2D caf20D cells. Cells were released from G1 into 200 mMHU
for 45 min at 25C. Polysome/monosome ratio (Poly/Mono) at the global level or on Clb5 mRNA was plotted for each strain using rad53-K227A as a reference.
Error bars represent the SD of two independent experiments.
(B) Mad2, Pgk1, and Rps6 protein distribution across the sucrose gradient was analyzed by western blotting in the absence or in the presence of EDTA/RNase I.
(C) Expression of Clb5-HA was followed throughout the cell-cycle progression in rad53-K227A, rad53-K227A caf20D, rad53-K227A mad2D, and rad53-K227A
mad2D caf20D cells by western blot analysis. Pgk1 and Ponceau S were used as loading controls. Cells were released from G1 into 200 mM HU at 25C. Clb5/
Pgk1 signal ratio was plotted for each condition, using rad53-K227A and rad53-K227A mad2D cells at 60 min as a reference. Error bars represent the SD of two
independent experiments for rad53-K227A versus rad53-K227A caf20D cells and of three independent experiments for rad53-K227A mad2D versus rad53-
K227A mad2D caf20D cells. Cell-cycle progression of rad53-K227A mad2D and rad53-K227A mad2D caf20 D cells was determined by FACS analysis.
(D) BrdU ImmunoPrecipitation and quantitative PCR on four early (ARS305, ARS306, ARS607, and ARS308) and one late (ARS106) origins in rad53-K227A
mad2D and rad53-K227A mad2D caf20D cells. Cells were released from G1 into S-phase for 45 min at 25C in the presence of 200 mMHU and 200 mg/ml BrdU.
BrdU fold increase was calculated as a ratio: IP/input, normalized against BrdU signal of rad53-K227A mad2D. Error bars represent the SD of two independent
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(E) Cells were spotted in 2-fold serial dilutions on YPDA/HU plates. Relative growth was assayed after 2 days of culture at 28C. The rad53-K227A allele is marked
as rad53.
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Figure 5. Mad2 Affects the Recruitment of
the Translational Machinery
(A and B) rad53-K227A CAF20-HA, rad53-K227A
mad2D CAF20-HA cells were released from G1
into S-phase at 25C in 200 mM HU for 45 min.
Proteins interacting with Caf20 (A, ribosomal pro-
teins; B, initiator factors) were co-immunoprecip-
itated using an anti HA antibody and identified by
mass spectrometry. Statistically significant differ-
ences between rad53-K227A and rad53-K227A
mad2D cells were plotted on a logarithmic scale so
that higher interaction in rad53-K227A mad2D
cells is shown as a positive number. (Red) Inter-
actors enriched in rad53-K227A mad2D cells;
(green) interactor enriched in rad53-K227A cells.
(C) Model for the translational regulation of the
S-phase cyclin mRNAs by Mad2. Mad2 regulates
the affinity of Caf20 for the translational machinery.
Mad2 decreases the association Caf20/ribosomes
while it stabilizes the association Caf20/Cdc33.Mad1, Mad3, and Bub3. Moreover, since Mad1 also favors the
proper localization of Mad2 at the kinetochore during mitosis
and at the nuclear pore during interphase (Campbell et al.,
2001; De Souza et al., 2009; Lee et al., 2008; Lussi et al.,
2010), our results imply that the S-phase function of Mad2 influ-
encingClb5 expression does not depend on its localization at the
kinetochore or at the nuclear pores. We ruled out a contribution
of Mad2 in promoting Clb5 transcription or in regulating its
degradation. Our results rather indicate that Mad2 promotes
an optimal Clb5 protein synthesis.
Previous high-throughput studies have already identified
some interactions between Mad2 and translational factors
(Table S1), and to our knowledge, Mad2 is the only component
of the spindle checkpoint which presents such interactions.
Here we found that Mad2 co-sediments with translating
ribosomes (Figure 4B) and that Mad2 directly promotes the
translation of Clb5 mRNA via a Caf20-dependent mechanism
(Figure 4A). We observed that Caf20 binds Clb5 mRNA, regard-
less of the presence or the absence of Mad2 (Figure S5). Recent
studies demonstrated that Caf20 is recruited onto mRNAs via its
interaction with the eIF4E factor, or via its fixation on the 30UTR
motif present on mRNAs. Interestingly, Clb5 and Clb6 mRNA
share the properties of the 4E-independent recruitment. Indeed,
both of thempresent a Caf20 consensus sequence in their 30UTR
(‘‘AUAUAUAUGUAUAUA’’ localized 100 nt after the stop codonMolin Clb5 mRNA). We found that Mad2
changes the affinity of Caf20 for its pro-
tein partners (Figures 5A and 5B). In the
absence of Mad2, the association of
Caf20 with the translational machinery in-
creases, probably negatively regulating
the translation rate. In parallel, in the
absence of Mad2, Caf20 has less
affinity for eIF4E (Figure 5C). We have
no direct evidence to argue for a
competition between eIF4E and the
translation machinery, but it is interestingto note that the same tendency has already been observed for
a Caf20 mutant that has a defective eIF4E binding (Castelli
et al., 2015).
We also found that, in response to replication stress, Rad53
controls Clb5 protein degradation (Figure 3). Interestingly,
Clb6 protein degradation upon replication stress is also
dependent on Rad53 (Palou et al., 2010). Although Clb5
stabilization occurs in response to both replication stress and
intra-S DNA damage (MMS, treatment), the mechanisms
seem different (Germain et al., 1997). In particular, the proteol-
ysis inhibition observed in the presence of DNA damage is
independent of the checkpoint proteins Mec1 and Rad53 (Ger-
main et al., 1997). This observation could explain why rad53-
K227A mad2D cells are specifically sensitive to HU and not
to other DNA damaging agents. Contrary to Rnr1, whose tran-
scription level is maintained during the duration of S-phase
upon replication stress through a Rad53 dependent mecha-
nism (Figure S3D; Travesa et al., 2012), we note that we did
not find evidence for a contribution of Rad53 in prolonging
Clb5 or Clb6 transcription upon replication stress (Figures 3
and S3D).
Importantly, the Rad53-Mad2 synergistic and specific effect in
response to replication stress seems to be at least partially
conserved between different yeast species. Indeed, previous
observations in S. pombe also underlined that (1) MAD2 andecular Cell 70, 628–638, May 17, 2018 635
CDS1 (RAD53 homolog) exhibit a negative genetic interaction in
the presence of replication stress; (2) this interaction is specific
for MAD2 over the other components of the spindle checkpoint
(MAD1, MAD3, and BUB1); and (3) this interaction is specific to
the cellular response to replication stress and not to DNA dam-
age (Sugimoto et al., 2004). However, while in S. pombe the
APC is hyperactivated in the absence of Mad2, we did not find
any increase in APC activity in S. cerevisiae (no modification of
Clb2 degradation). On the contrary, we proposed that Mad2 in-
terferes with the translation process. It is particularly interesting
to note that physical interactions between the spindle check-
point protein Mad2 and the translational machinery have already
been identified in different organisms including plants and hu-
mans (Table S1).
The Mad2 function described in our paper may have relevant
implications for cancer cells. Expression of SAC proteins is
often deregulated in tumor cells. However, Mad2 deregulation
is particularly prominent over the other spindle checkpoints
proteins. Oncomine database analysis revealed that only 2%
of cancer cells show an upregulated expression of Mad1,
whereas 18% of cancer cells exhibit Mad2 upregulation. This
specific increase is particularly relevant in colorectal cancer,
in which one-third of the tumor tissue analyzed exhibits an
overexpression of Mad2. An additional role of Mad2 out
of the spindle checkpoint could explain the particular promi-
nence of Mad2 deregulation. It is also worth noting that many
cancer cells exhibit a delocalization of Mad2 protein from the
nucleus to the cytoplasm (Fung et al., 2007; Li et al., 2003), a
cellular compartment in which Mad2 is not functional as a spin-
dle checkpoint player (Kasai et al., 2002) but could be fully
functional as a regulator of the translation process. Given that
differences exist between yeast and mammals at the level of
4E-BP regulation, more work will be required to address
whether Mad2 affects protein translation also in mamma-
lian cells.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse monoclonal anti-phosphorylated Rad53 In house (Fiorani et al., 2008) Clone F9
Mouse monoclonal anti-phosphorylated histone
H2X (ser139)
Merck Clone JBW301 Cat #05-636
Mouse monoclonal anti-Pgk1 ThermoFisher Scientific Clone 22C5D8 Cat #459250
Rabbit polyclonal anti-Clb2 Santa-Cruz Biotechnology Cat #sc9071
Mouse monoclonal anti c-MYC (clone 9E10) Santa Cruz Biotechnology Cat #sc-40
Mouse monoclonal anti HA Biolegend Clone 16B12 Cat #901503
Mouse monoclonal anti BrdU MBL Clone 2B1 Cat #MI-11-3
Rabbit polyclonal anti Mad2 In house (Vernieri et al., 2013) Clone IEO447SI353F
Rabbit polyclonal anti Rps6 ABCam Cat #ab40820
Goat anti-Mouse IgG (H + L)-HRP
Conjugate
Bio-Rad Cat #1706516
Goat anti-Rabbit IgG (H + L)-HRP
Conjugate
Bio-Rad Cat #1706515
Chemicals, Peptides, and Recombinant Proteins
Hydroxyurea Sigma-Aldrich Cat #H8627
Methyl methanesulfonate (MMS) Sigma-Aldrich Cat #129925
MG132 Sigma-Aldrich Cat #M8699
Cicloheximide Sigma-Aldrich Cat #C7698
Camptothecin Sigma-Aldrich Cat #208925
Anti-HA.11 Epitope Tag Affinity Matrix Biolegend Cat #900801
Dynabeads Protein A ThermoFisher Scientific Cat #10001D
Critical Commercial Assays
Genomic DNA buffer genomic set QIAGEN Cat #19060
Genomic tip 100/G QIAGEN Cat #10243
Rneasy Mini Kit QIAGEN Cat #74104
PCR purification kit QIAGEN Cat #28106
QuantiFast SYBR green PCR kit QIAGEN Cat #204054
Deposited Data
Proteomic raw data Peptide Atlas repository http://www.peptideatlas.org/PASS/
PASS01156
Raw Data Mendeley Data http://dx.doi.org/10.17632/wwcrg942cf.1
Experimental Models: Organisms/Strains
All Saccharomyces cerevisiae yeast strains used in
this study were W303 derivatives; they are listed in
Table S3
This study N/A
Oligonucleotides
See Table S4 for a list of oligonucleotides used in
this study
Sigma-Aldrich N/A
Recombinant DNA
pCH12 (GAL1- rad53-D339A) Pellicioli et al., 1999 N/A
(Continued on next page)
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Software and Algorithms
Image Quant software GE Healthcare https://www.gelifesciences.com/shop/
protein-analysis/molecular-imaging-for-
proteins/imaging-software/imagequant-
tl-8-1-p-00110?current=29000737
Image Lab software Bio-Rad http://www.bio-rad.com/en-ch/product/
image-lab-software
Perseus Max Planck Institute http://www.perseus-framework.org
CellQuest BD Biosciences http://www.bd.com/en-uk/products/
molecular-diagnostics/cytometric-
analysis-productsCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Marco
Foiani (marco.foiani@ifom.eu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The list of yeast strains used in this study is available in the Key Resources Table (Table S3). Yeast strains are derived from W303
background (S. cerevisiae). All strains, except cdc33mutants, are corrected with the wild-type RAD5 locus. Gene deletions and car-
boxy-terminal tags were carried out using a standard PCR-based strategy to amplify resistance cassettes with appropriate flanking
sequences, and replacing the target gene by homologous recombination. All strains, except rad53-D339Amutants, carry a repetition
of the thymidine kinase (TK) at the URA3 locus in order to allow BrdU incorporation (Lengronne et al., 2001). GAL1- rad53-D339A
plasmid was previously described in (Pellicioli et al., 1999). Strains were grown at 25C in yeast extract/peptone with 2% glucose
(YPD) or in synthetic complete medium lacking uracil. Exponentially growing cells (107cells/ml) were arrested in G1 using a factor
(5 mg/ml). Before release, cells were washed in YP. HU was added at 0.2M, BrdU at 0.2mg/ml and MG132 at 100 mM.
METHODS DETAILS
Drug sensitivity assay
Cells were grown in liquid culture overnight, counted, adjusted to 8X107cells/ml and diluted before being spotted on YPD plates sup-
plemented with adenine (YPDA) containing indicated concentrations of HU, MMS or Camptothecin. Plates were incubated for 2 days
at 28C. Note that serial dilutions of 1:2 were made for rad53mutant cells plated on HU while serial dilutions of 1:5 were made in all
other cases. rad53-D339A mutants were spotted on synthetic growth medium plates deprived of uracil to maintain the plasmid
selection.
Protein extraction and Western Blot analysis
Protein extracts for western blotting were prepared following cell fixation using trichloroacetic acid and analyzed by SDS-polyacryl-
amide gel electrophoresis (gel 4/15%Criterion TGX, Biorad). Briefly, cells were quickly spun down and the pellet was resuspended in
20% TCA and lysed by bead beating. Lysate and precipitate/debris was mixed with 200 mL 5% TCA and pelleted. The pellet was
resuspended in 100 mL Laemmli buffer 1X (b-mercaptoethanol as reducing agent) and 50 mL Tris base 1M, boiled for 5 min. After
centrifugation, the supernatant was transferred in new tubes.
Antibodies used for detection are listed in the Key Resources Table. Detection was done through electrogenerated chemilumines-
cence (ECL, GE- Healthcare). Quantification was done using Image Lab software (Bio-Rad).
2D Gel Electrophoresis of replication intermediates
200ml of exponentially growing cell culture was harvested in the presence of 1% sodium azide and cooled on ice for 15minutes. Cells
were then subjected to in vivo psoralen cross-linking. Briefly, cells were washed, resuspended in 5ml of cold water in small Petri
dishes and kept on ice. 300 mL of 4,50,8-tri-methyl-psoralen solution (0.2 mg/ml in EtOH 100%) was added prior to extensive resus-
pension by pipetting, followed by 5 min of incubation in the dark and then 10 min of UV irradiation at 365 nm (Stratagene UV
Stratalinker). The procedure was repeated 3 times. Cells were centrifuged and resuspended in 5ml of nuclear isolation buffer
(17% glycerol, 50mMMOPS, 2mMMgCl2, 150mMKacetate, 0.5mM spermidine, 0.15mM spermine, pH 7.2) andmechanically lysed
using an equal volume of glass beads (Sigma, G8772). After centrifugation (8000 rpm, 10min, 4C), the pellet was resuspended in 5mle2 Molecular Cell 70, 628–638.e1–e5, May 17, 2018
of G2 buffer (Genomic extraction kit, QIAGEN). Genomic DNA extraction was performed according to manufacturer recommenda-
tions. 4 mg of genomic DNAwas digested overnight with 200 units of NcoI enzyme and then precipitated with 1/8 volume of Kacetate
and one volume of isopropanol. Signals were detected following 2D gel electrophoresis (Brewer and Fangman, 1987) and standard
Southern blot procedures using a probe against ARS305 (Chr III 39002-40063). Quantification of bubble arc signal was performed
using the Image Quant software (GE Healthcare).
BrdU immuno-precipitation
150 mL of exponentially cell culture was synchronized in G1, released into S-phase in the presence of 200mM HU and 200 mg/ml
BrdU. At different time points, cells were harvested in the presence of 1% sodium azide and cooled on ice for 15 minutes. Cells
were then washed in 20ml of TE and the genomic DNAwas extracted using the Genomic extraction kit (QIAGEN) according to manu-
facturer recommendations. BrdU immuno-precipitations were performed as previously described (Bermejo et al., 2009; Katou et al.,
2003). DNA was then resuspended overnight in 250 mL of TE and then shared using the Bandelin UW2070 sonicator (6 pulses, 20%
power, 20 s/pulse). Immediately before immunoprecipitation, the genomic DNA was denatured at 100C for 10 minutes, cooled
immediately on ice and supplemented with 100 mL of ice cold PBS 2x and 200 mL of ice cold-PBS 1X-2% BSA-0,2% Tween20.
BrdU immunoprecipitation was carried out overnight using 14 mg of genomic DNA, 20 mL of Protein A-magnetic Dynabeads (Thermo-
fisher) and 4 mg of anti-BrdU antibody (clone 2B1, MBL, MI-11-3). 700ng of DNA was kept as an input. After immuno-precipitation,
beads were washed 2 times with ice cold lysis buffer (50mM HEPES-KOH pH7.5, 140mM NaCl, 1mM EDTA, 1% Triton x100, 0.1%
Na-deoxycholate), 2 times with ice-cold lysis buffer + 500mM NaCl, 2 times with ice-cold washing buffer (10mM Tris-HCl pH8.0,
250mM LiCl, 0.5% NP40, 0.5% Na-deoxycholate, 1mM EDTA) and once with TE. Beads were then resuspended in 50 mL of elution
buffer (50 mM Tris-HCl pH8, 10 mM EDTA, 1% SDS), incubated at 65C for 10 minutes with shaking. After centrifugation and mag-
netic attachment, the supernatant was transferred into a new tube. 49 mL of TE and 1 mL of proteinase K 50mg/ml was added to both
IP and input tubes. Tubes were incubated at least 2 hours at 37C. DNA was then purified using the PCR purification Kit (QIAGEN),
eluted in 50 mL of the elution buffer of the kit and precipitated at 20C overnight in the presence of 40mM Na- acetate, 1 mL of
glycogen and 132.5 mL of 100% ethanol. After centrifugation, the pellet was washed in 70% ethanol, dried and resuspended in
50 mL of bi-distillated water. Input DNA was diluted 50 times and IP DNA 10 times before quantitative PCR.
Quantitative PCR
Primers used for quantitative PCR are listed in Table S4. Quantitative PCR was prepared using QuantiFast SYBR green PCR kit
(QIAGEN) and run on the Lightcycler 480II (Roche) according to the manufacturer’s recommendations. Absolute DNA quantification
was deduced from standard curve (100; 10; 1 and 0.1ng of input DNA).
RNA extraction and reverse transcription
Total mRNAs were extracted from 2.5x107 cells using the RNeasy mini kit (QIAGEN). Reverse transcription was performed using the
SuperScript VILO cDNA synthesis kit (Invitrogen) with 2 mg of total RNA as starting material. 1/160 of the cDNA reaction was used for
quantitative PCR. Two reporter genes (TAF10, ALG9) were chosen for their robustness (Teste et al., 2009) and their distance from
replication origins (minimum 12 kb). Normalization was done by dividing the expression of the gene of interest by the average of
the two reporter genes.
Fluorescence-activated cell sorter (FACS) analysis
1x107cells were collected by centrifugation, and resuspended overnight in 70% ethanol/ 250mM Tris-HCl (pH 7.5) solution. Cells
were then centrifuged and resuspended in 0.5M Tris-HCl (pH 7.5), resuspended in the same buffer containing 2 mg/ml of RNaseA
and incubated at 37C for at least 2h. Cells were then resuspended in 500 mL of 200mM Tris-HCl (pH 7.5), 200mM NaCl, 80mM
MgCl2 supplemented by 50 mg/ml of propidium-iodide (Sigma). Samples were then diluted 10-fold in 50mM Tris-HCl (pH 7.5) and
analyzed using a Becton Dickinson FACScan and the Cellquest software.
Non-denaturing protein Co-immunoprecipitation
2*109 cells were used for each immunoprecipitation. Cell pellet was washed two times in 50ml of TE, and resuspended in 1.6ml of JS
buffer (35mMHEPES pH7.5, 105mMNaCl, 0.7% glycerol; 0.7% Triton, 1mMMgCl2, 3.5mMEDTA, 1 tablet of Phostop-phosphatase
inhibitor Roche, 1 tablet of Ultra-protease inhibitor-Roche). The same quantity of zirconium beads was added to the cell suspension
and cells were mechanically disrupted at 4C thanks to the use of a bead-beater. Cell lysate was collected using a gel tip (thin diam-
eter to avoid beads) and proteins were quantified using the Bradford Protein Assay (Biorad). Proteins associated to Caf20-HA were
immunoprecipitated overnight using 80 mL of Sepharose beads covalently coupled to an anti-HA antibody (Biolegend). After immu-
noprecipitation, beads were washed once with JS buffer, two times with JS buffer supplemented with 350 mM NaCl, and two times
with JS buffer. At the last step, beads were resuspended in 40 mL of Laemmli buffer, boiled during 6minutes at 98C, and centrifuged.
The supernatant was analyzed by SDS-polyacrylamide gel electrophoresis. Note that pre-lubricated tubes were used at all stages to
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Mass-spectrometry (MS)
Protein digestion and peptide preparation
Gel lanes were processed according to STAGE-diging protocol (Soffientini and Bachi, 2016). The entire protocol occurs in a p1000
tip (Sarstedt 70.762.100) filled at the orifice with a double C18 Empore Disk (3M, Minneapolis, MN) plug, named STAGE-diging tip.
Briefly, after Coomassie staining, the entire lane was carefully cut into 1 mm3 cubes and transferred into the STAGE-diging tip.
These gel cubes were dehydrated with 100% acetonitrile (CAN, Carlo Erba) and rehydrated in 100 mM NH4HCO3 (Sigma) twice
before being dehydrated by the addition of ACN. To ensure that the gel pieces do not create a sticky surface on the C18, all the so-
lutions were added with a gel-loader tip. The removal of solutions was accomplished by centrifugation at 1800 rpm using the com-
mercial tip box as holder. Reduction of protein disulfide bonds was carried out with 10 mM dithiothreitol (DTT) in 100 mM NH4HCO3
and subsequent alkylation was performed with 55 mM iodoacetamide (IAA) (Sigma), in complete darkness, in 100 mM NH4HCO3, at
room temperature for 30min. BothDTT and IAAwere removed by centrifugation or by syringe as previously described. The gel pieces
were rehydrated and dehydrated with 100 mM NH4HCO3 and ACN respectively prior to digestion. Gel pieces were rehydrated with
40 mL of Trypsin (12.5 ng/mL in 100 mMNH4HCO3), after fewminutes 60 mL of NH4HCO3 were added and samples were incubated at
37Co/n in a commercial tip box filled bywater on the bottom to ensure that buffer will not evaporate. The digestion solution was then
forced through the double plug with a syringe and the flow through was collected. Samples were acidified with 100 mL of 0.1% formic
acid (FA, Fluka), forced with the syringe and collected as flow-through. In this way the desalting of peptides occurs. Peptides were
eluted twice by adding 100 mL of a solution composed of 80% ACN, 0.1% FA, an extra step of extraction with 100% ACN was per-
formed and then all the eluates were dried in a Speed-Vac and resuspended in 15 mL of solvent A (2% ACN, 0.1% formic acid). 3 mL
were injected for each technical replicate on the Q-Exactive –HF mass spectrometer.
MS analysis and proteins quantification
Mass spectrometry analysis was carried out by LC–MS–MS on a quadrupole Orbitrap Q Exactive HF mass spectrometer (Thermo
Scientific). Peptide separation was achieved on a linear gradient from 95% Solvent A to 50% Solvent B (80% acetonitrile, 0.1% for-
mic acid) over 20 min and from 50% to 100% Solvent B in 2 min at a constant flow rate of 0.25 ml min1 on a UHPLC Easy-nLC 1000
(Thermo Scientific), where the LC system was connected to a 25 cm fused-silica emitter of 75 mm inner diameter (New Objective),
packed in house with ReproSil-Pur C18-AQ 1.9 mm beads (Maisch) using a high-pressure bomb loader (Proxeon). MS data were ac-
quired using a data-dependent top15 method for HCD fragmentation.
Survey full scan MS spectra (300–1750 Th) were acquired in the Orbitrap with 60,000 resolution, AGC target 1e6, IT 120 ms. For
HCD spectra the resolution was set to 15,000, AGC target 1e5, IT 120 ms; normalized collision energy 28 and isolation width 3.0 m/z.
2 technical replicas of each sample were carried out. Raw data were processed with MaxQuant version 1.5.2.8. Peptides were
identified from theMS–MS spectra searched against the uniprotKB_S.Cerevisiae database (3845 entries canonical + isoforms) using
the Andromeda search engine, in which trypsin specificity was used with up to two missed cleavages allowed.
Cysteine carbamidomethylation was used as a fixed modification, methionine oxidation and protein amino-terminal acetylation as
variable modifications. The mass deviation for MS and MS–MS peaks was set at 4.5 and 20 ppm respectively. The peptide and pro-
tein false discovery rates (FDRs) were set to 0.01; the minimal length required for a peptide was six amino acids; a minimum of two
peptides and at least one unique peptide were required for high-confidence protein identification. The lists of identified proteins were
filtered to eliminate reverse hits and known contaminants.
Label-free analysis was carried out, including a ‘match between runs’ option (time window of 5 min). A minimum ratio count of 2
was considered and the ‘LFQ intensities’, which are the intensity values normalized across the entire dataset, were used. 2 Biological
and 2 technical replicates for every condition were submitted in a single MaxQuant run.
Statistical t test analyses were done using the Perseus program (Version 1.5.1.6) in the MaxQuant environment. For all the statis-
tical analysis an FDR 0.05 was applied using a permutation test (500 randomizations) and S0 = 1.
Gene ontology annotation for biological process andmolecular function wasmanually added by uniprot.org. Proteins belonging to
translational process and ribosomal assembly (list of GO selected is reported in the Table S2, sheet Go_table) were filtered and only
proteins with a valid ratio in both biological replicates were selected.
Ratios of the 2 biological replicates were averaged and plotted in logarithmic scale. Standard deviations were calculated and rep-
resented on the plot.
RNA co-immunoprecipitation
2*109 cells were used for each immunoprecipitation. Proteins were fixed onto RNA with 1% formadehyde at 4C. In vivo crosslinking
was stopped by addition of 0.1M glycine. Cells were washed four times with 20mL of water. After centrifugation, the cell pellet was
resuspended in 0.8ml of Buffer A (20mM Tris-HCl pH8, 140mM NaCl, 1 mM MgCl2, 0.5 mM DTT, 1 tablet of Phostop-phosphatase
inhibitor Roche, 1 tablet of Ultra-protease inhibitor-Roche, and 80U/ml RNasin-Promega).The same quantity of zirconium oxide
beads was added to the cell suspension and cells were mechanically lysed thanks to the use of a bead-beater. The lysate was recov-
ered with a gel tip (to avoid beads) and centrifuged. Proteins of the supernatant were quantified using the Bradford Protein Assay
(Biorad). 20mg of protein extract and 120 mL of Sepharose beads coupled with anti-HA antibody were used for overnight immuno-
precipitation. 1mg of protein extract was kept as an input. After immunoprecipitation, beads were washed 3 times shortly with
Buffer A, two times 15 minutes with Buffer A, and three times with the Rnase III buffer (10mM Tris-HCl pH8, 10mM MgCl2, 60mM
NaCl, 1mM DTT, 10U/ml RNasin-Promega). At the final wash, beads were resupended in 100 mL of Rnase III buffer supplementede4 Molecular Cell 70, 628–638.e1–e5, May 17, 2018
by 40U RNasin, 1U DNase I, 2U RNase III, and incubate 10 minutes at 37C. RNase III was deactivated by addition of 900 mL of
Buffer E (20mM Tris-HCl pH8, 140mM NaCl, 0.5% NP40, 1mM EDTA, 0.5 mM DTT, 40U/ml RNasin-Promega). Beads were further
washed three more times with buffer E. At the last wash, beads were resuspended in 270 mL of proteinase K buffer (10mM Tris-HCl
pH8, 200mM NaCl, 1mM EDTA, 0.1% SDS, 10U/ml RNasin-Promega). Proteinase K buffer up to 270 mL was also added to the input
samples. 50 mg of proteinase was added to IP and input and the samples were incubated for two hours at 40C. After centrifugation,
the supernatant was transferred into a new tube and incubated overnight at 65C to reverse the crosslink. 750 mL of Trizol and 200 mL
of Chloroform was added to each sample and the aqueous phase was collected. RNA was precipitated overnight at20C by addi-
tion of 500 mL of propanol and 1 mL of glycogen. After centrifugation, RNA pellet was washed in 70% ethanol and resuspended in
30 mL of bi-distillated water for IP samples and 20 mL of water for Input samples. Total mRNAs were then reverse-transcribed and
amplified by quantitative PCR.
Polysome profiling
Cell lysis. 2*109 cells were used for each polysome profiling experiment. 100 mg/ml of cycloheximide was added for 5minutes to each
sample to ‘‘freeze’’ ribosomes onto RNAs. Cells were centrifuged, washed two times with 7 mL of pre-lysis buffer (20mM Tris-HCl
pH8, 50mM KCl, 10mMMgCl2, 1mM DTT, 100mg/mL cycloheximide, 200 mg/mL heparin) and then resuspended in a volume of lysis
buffer (20mM Tris-HCl pH8, 50mM KCl, 10mM MgCl2, 1mM DTT, 100mg/mL cycloheximide, 200mg/mL heparin, Ultra-protease in-
hibitor 1X-Roche, and 40U/ml RNasin-Promega) equivalent to the cell pellet size. An equal volume of zirconium beads was added
to the cell suspension and cells were mechanically lysed thanks to use of a bead-beater. Lysate was recovered and cleared by
centrifugation.
Polysomal profiles. 15 and 50% sucrose buffers were prepared in 50mM NH4Cl, 50mM Tris-Acetate, 12mMMgCl2, 1mM DTT. To
obtain a linear gradient, we used the Gradient Maker device (Hoefer SG) equipped with tubes adapted for a SW41 rotor. We used
11ml of each sucrose buffer in each gradient tube. Cytoplasmic extracts with equal amounts of RNA were loaded on the 15%–
50% sucrose gradient and centrifuged at 4C in a SW41Ti Beckman rotor for 3h30 min at 39,000 rpm Absorbance at 254 nm was
recorded by BioLogic LP software (Bio-Rad) and fractions (0.5 ml each) were collected for subsequent RNA extraction.
To distinguish between active polysomes and co-sedimenting mRNPs, we treated our samples with 40 mMEDTA prior to gradient
loading. Sucrose gradients were also supplemented with 30 mM EDTA and prepared without Mg2+.
RNA purification. The different fractions were pooled into 3 major fractions: cytoplasm, monosomes and polysomes. 100 mg/ml of
proteinase K and 1% SDS was added to each major fraction. The fractions were then incubated for 1h30 at 37C. 200mM NaCl and
1/4 volume of acidic phenol/chloroform/isoamyl alcohol (25:24:1) was added to the samples and the aqueous phase was transferred
to a new tube. RNAswere precipitated overnight at20Cafter addition of 1 mL of glycogen and 1 volume of isopropanol. After centri-
fugation, RNA pellet was washed in 70% ethanol and resuspended in 120 mL of bi-distillated water. mRNAs were then re-purified
using the RNeasy mini kit (QIAGEN) and eluted in 80 mL of the elution buffer of the kit. RNAs were again precipitated overnight at
20C after addition of 40 mM Na-acetate, 1 mL of glycogen and 212 mL of ethanol 100%. After centrifugation, RNA pellet was
washed in 70% ethanol and resuspended in 40 mL of bi-distillated water. The RNA concentration was measured using nanodrop.
mRNAs were then reverse-transcribed and amplified by quantitative PCR.
Quantification and statistical analysis
Number of replicates and statistical tests are specified in the corresponding figure legends. In all graphs, standard deviations are
represented by error bars. Western blots were quantified using the Image lab software (Biorad). Raw files (.scn) were used to allow
the quantification of linear and non-saturated signals. 2D gels were quantified using the Image Quant software (GE Healthcare). The
mass spectrometry analysis is described in the corresponding paragraph of the STAR Methods.
Data and software availability
Proteomic data as raw files, total proteins and peptides identifiedwith relative intensities and search parameters have been loaded on
the Peptide Atlas repository (http://www.peptideatlas.org/PASS/PASS01156). The remaining raw data have been deposited to Men-
deley Data and are available at http://dx.doi.org/10.17632/wwcrg942cf.1.Molecular Cell 70, 628–638.e1–e5, May 17, 2018 e5
